.

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi to invest €350 million in Canadian vaccine facility *       Expansion demonstrates...
Dear Consumer: Subject: Changes in latex content in the stopper of the diluent for reconstitution of YF-VAX® (Yellow Fever Vaccine) supplied to the...
- Canada's National Advisory Committee on Immunization (NACI) recognizes superior efficacy of high-dose flu vaccine for adults +65 years compared to...
August 13th, 2016  - First dengue immunization public program in the Americas starts today targeting broad age range of individuals at highest...
Quebec Science story strikes Green Gold Award winning writer outlines the pharmaceutic potential of plants   Montreal May 27, 2016 — Canada’s...
Canada’s Top Student Scientist Recognized at Sanofi Biogenius Canada National Final Iveta Demirova, 16, student at New Westminster Secondary School...
Canada’s National Advisory Committee on Immunization recognizes superior efficacy of high dose vaccine for adults 65 years of age and older...
News Release     Montreal, November 17, 2015 – On behalf of the Board of Directors of Canada’s Research-Based Pharmaceutical Companies (Rx&...
- Sixty-one per cent of Canadians surveyed say the availability of an influenza vaccine covering four strains instead of three would make them more...
Every year, Sanofi Pasteur works in collaboration with the Canadian Nurses Foundation (CNF) to award a $5,000 scholarship to a nursing student who is...

Pages